On Monday, a federal judge in Boston ruled that the termination of grants from the National Institutes of Health signals the end of efforts aimed at diversity-related research topics. Trump’s administration has claimed this decision was “invalid and illegal,” citing discrimination against racial minorities and the LGBTQ community.

US District Judge William Young stated in a non-judicial trial that the NIH breached federal law by capriciously canceling over $1 billion in research grants linked to diversity, equity, and inclusion initiatives.

Judge Young indicated he is reinstating grants awarded to organizations that advocated for such initiatives in democratically led states. He also mentioned that as the case unfolds, more significant decisions might follow.

“This amounts to racism and discrimination against the American LGBTQ community,” remarked Young, a Republican appointee of President Ronald Reagan. “Government discrimination is profoundly wrong; I urge the court to prohibit it, and I will take action in due course.”

Discussing the end of grants for research addressing racial minority issues, Young expressed from the bench that he has “never witnessed such blatant racism” in his 40 years on the bench.

“You judge people of color based on their skin,” he stated concerning the Trump administration. “The Constitution does not permit that.”

The Department of Health and Human Services, representing the NIH and its parent organization, has not responded promptly to requests for statements.

Rachel Meelopol from the American Civil Liberties Union, who represents the grant recipients in the lawsuit, mentioned that Young’s ruling impacts hundreds of grants. The plaintiffs include the American Public Health Association and 16 states led by Massachusetts.

The NIH, the world’s premier funder of biomedical and behavioral research, has terminated approximately 2,100 research grants worth about $9.5 billion and an additional $2.6 billion in contracts since President Donald Trump took office in January. I signed on to protest the cuts last week.

These funding cuts reflect Trump’s broader agenda to reshape the government, reduce federal expenditures, and eliminate support for DEI programs and transgender healthcare. Another federal judge has temporarily blocked the administration’s plan to reduce 10,000 jobs across the NIH and other health agencies.

Trump has also enacted a series of executive orders mandating that institutions ensure grant funding does not support “gender ideology” and puts an end to what the administration deems “discriminatory” DEI programs. Conservative critics argue that these DEI initiatives unfairly target white individuals and others.

Aligned with Trump’s policy objectives, the NIH has directed staff to cease grant funding for research on DEI programs, issues facing transgender individuals, COVID-19 vaccine hesitancy, and funding beneficial to universities in China.

The trial presided over by Young on Monday focused on just a portion of the claims in the consolidated litigation regarding the funding cuts. He intends to consider additional claims later.

Young indicated he would allow political parties to present further evidence before making decisions regarding these claims and determine whether to restore grants beyond those allocated to the plaintiffs.

The cessation of NIH grants, coupled with delays in grant approvals and renewals, has reverberated across universities nationwide, many of which now face the loss of significant portions of their research budgets.

As a result, universities have initiated employment freezes, travel restrictions, reduced class sizes, furloughs, and layoffs.

Numerous universities depend on NIH grants for the majority of their research funding. For instance, Washington University, recognized as the top public institution for biomedical research, reported receiving roughly 1,220 grants from the NIH, totaling about $648 million last year, as per court documents.

Students and faculty at universities have expressed concerns that the funding confusion could lead to brain drain from the United States, as researchers increasingly seek positions abroad. This slowdown also threatens long-term research initiatives, including projects focused on banking and studying the brains of Alzheimer’s patients.

The Trump administration has aimed to reduce other critical research funding sources.

In February, US District Judge Angel Kelly halted regulations that severely restricted government payments for indirect research costs, including equipment, maintenance, utilities, and support staffing. The administration projected that this action would eliminate $4 billion in funding for research institutions.